| aCT | Adjuvant chemotherapy |
| aCRT | Adjuvant chemoradiotherapy |
| aRT | Adjuvant radiotherapy |
| CCRT | Concomitant chemoradiotherapy |
| CI | Confidence interval |
| CONSORT | Consolidated Standards of Reporting Trials |
| DSS | Disease-specific survival |
| ECS | Extra capsular spread |
| EORTC | European Organization for Research and Treatment of Cancer |
| 5-FU | 5-fluorouracil |
| HR | Hazard ratio |
| IC | Induction chemotherapy |
| ICRT | Induction chemoradiotherapy |
| KM | Kaplan–Meier |
| LP | Larynx preservation |
| LEDFS | Laryngo-esophageal dysfunction-free survival |
| LFS | Laryngectomy-free survival |
| LPFRS | Larynx Preservation Failure Risk Score |
| n.a. | Not available |
| n.s. | Not significant |
| NCDB | National Cancer Data Base |
| OPL | Open partial laryngectomy |
| OS | Overall survival |
| pCRT | Primary chemoradiotherapy |
| p(C)RT | Primary radiotherapy or primary chemoradiotherapy |
| pRT | Primary radiotherapy |
| QoL | Quality of life |
| R+ | Positive resection margin |
| SFX | Standard fractionation |
| TDRS | Total Dysphagia Risk Score |
| TLM | Transoral laser microsurgery |
| TL | Total laryngectomy |
| TPF | Docetaxel, cisplatin, 5-FU (an induction chemotherapy regimen) |
| TNM | Staging according to T = primary tumor, n = lymph node metastases, and M = distant metastases |
| rTNM | TNM of recurrent tumors |
| UICC | Union International Contre le Cancer (International Union against Cancer |